ESC Heart & Stroke 2021 Resources

Wednesday, 2 June 2021

Inaugural session

• Welcome and introduction (Jan Kovac)
• Introduction and welcome to the Conference (Wolfram Doehner, Alison Halliday)

Session 1: Cardiovascular and Stroke update 21 in times of COVID

Chairpersons: Alison Halliday, Wolfram Doehner

• Cardiovascular update 2021 (John Cleland)
• Neurology Stroke update 2021 (Matthias Endres)
• Is COVID 19 Thrombosis different? (Christiaan Vrints)

Session 2: Anticoagulation

This session is sponsored by Bayer AG. The scientific programme has not been influenced in any way by its sponsor.

Debate 1: Anticoagulation in AF at borderline risk

Chairpersons: Gregory Lip , Renate Schnabel

• AF with only one (non-sex) risk factor: When should we anticoagulate? (Tatjana S. Potpara)
• AF duration or AF “burden”, how to decide on anticoagulation? (Isabelle C. van Gelder)
• Discussion (Tatjana S. Potpara, Isabelle C. van Gelder)

Debate 2: Single, double or triple antithrombotic treatment in stroke prevention?

• How much anticoagulation is too much? – insights from COMPASS (Stuart J. Connolly)
• Single, dual or triple antiplatelet therapy for secondary stroke prevention? – insights from CHANCE, POINT, THALES and TARDIS (Karl Georg Häusler)
• Discussion (Karl Georg Häusler, Stuart J. Connolly)

Session 3: Risk factors and secondary prevention of stroke

Chairpersons: Christiaan Vrints, Mikhail Loukianov

• Relevance of lipids for stroke: from genetic epidemiology to clinical insights (Jemma Hopewell)
• Managing blood pressure in primary and secondary stroke prevention – clinical (with reflections on the guidelines) (Thomas Kahan)
• Discussion (Jemma Hopewell, Thomas Kahan)
• Behavioral and lifestyle stroke prevention – impact on stroke prevention (Maja-Lisa Lochen)
• Carotid disease surgery and/or stenting? (Richard Bulbulia)
• Discussion (Maja-Lisa Lochen, Richard Bulbulia)

Thursday, 3 June 2021

Session 4: Interdisciplinary stroke management and pathways

This session is sponsored by Medtronic. The scientific programme has not been influenced in any way by its sponsor.

Chairpersons: Alison Halliday, Miloš Táborský, Jan Kovac, Wolfram Doehner)

• Welcome, introduction (Alison Halliday, Miloš Táborský)
• Cardiologist’s tasks on a stroke unit (Wolfram Doehner)
• Troponin elevation in acute stroke – how much myocardial damage is there? (Jan F. Scheitz)
• Importance of heart and brain centres (Patrick Goldstein)
• Network experiences – pathways for extended stroke centres (Marta Rubiera)
• Discussion (Marta Rubiera, Patrick Goldstein, Jan F. Scheitz, Wolfram Doehner)

Session 5: Mechanical Thrombectomy and adjacent therapies - Teaching session: Acute stroke neurointervention: what is new?

Chairpersons: Petr Widimsky, Marc Ribo

• Thrombus constitution and relation with thrombectomy result (Christophe Cognard)
• LVO strokes: Directly to thrombectomy center or initially to the nearest stroke unit? (Marc Ribo)
• Discussion (Christophe Cognard, Marc Ribo)

Session 6: Interventions for secondary stroke prevention

Chairpersons: Jan Kovac, Robert Hatala)

• LAA Closure is here to stay for AF Stroke prevention (Ulf Landmesser)
• Carotid interventions – the current evidence (Alison Halliday)
• Is cerebral protection necessary for all trans catheter cardiac interventions? (Andreas Baumbach)
• PFO related stroke interventions – knowns and unknowns (Jan Kovac)
• Discussion (Jan Kovac, Andreas Baumbach, Ulf Landmesser, Alison Halliday)

Friday, 4 June 2021

Session 7: Workshop session: Clinical cases and Guidelines

Workshop 1: “Cryptogenic stroke” how to... (diagnostic pathway, how and who should organise it)

Chairpersons: Jan Kovac, Sandor Nardai

• Explaining Workshop concept (Jan Kovac, Sandor Nardai)
• Case based learning and discussion (George Ntaios, Robert Hatala)
• Summary talk: the role of the cardiologist (Renate Schnabel)
• Panel debate Q&A (Robert Hatala, George Ntaios, Renate Schnabel)

Live abstract discussion 1: Risk Factors and Prevention

Chairpersons: Wolfram Doehner, Jan Kovac, Alison Halliday

• Cardiac risk factors for stroke: a comprehensive Mendelian Randomization study (Simon Frerich)
• Maternal hypertensive disorders during pregnancy and severe cardiovascular diseases in the offspring (Fen Yang)
• Evaluating risk of paroxysmal atrial fibrillation presence in non-cardioembolic ischemic stroke using AI (Changho Han)

Workshop 2: Acute stroke reperfusion treatment

Chairpersons: Jan Kovac, Sandor Nardai

• Case based learning and discussion (Jeroen Boogaarts)
• Summary talk (Jeroen Boogaarts)
• Panel debate Q&A (Wim H. van Zwam, Jeroen Boogaarts)

Live abstract discussion 2: Acute stroke and Intervention

Chairpersons: Wolfram Doehner, Jan Kovac, Alison Halliday

• Long-term follow-up from the LAACS trial (Christoffer Valdorff Madsen)
• Stent retriever versus direct aspiration thrombectomy as endovascular treatment of acute ischemic stroke, single centre experience from 2012-2020 (Ivan Poledník)
• Troponin elevation in acute ischaemic stroke - Insights from the Stroke Induced Cardiac FAILure (SICFAIL) study (Felipe A. Montellano)

Workshop 3: Combined anticoagulation / antiplatelet regimes in complex casesChairpersons: Jan Kovac, Sandor Nardai

• Case based learning and discussion (Diana Gorog, Petr Widimsky)
• Summary talk (Tatjana S. Potpara)
• Panel debate Q&A (Petr Widimsky, Tatjana S. Potpara, Diana Gorog)

Session 8: Final summary, award ceremony and conclusion of the conference

Chairpersons: Wolfram Doehner, Jan Kovac, Alison Halliday

• Poster award ceremony (Wolfram Doehner, Jan Kovac, Alison Halliday)
• Summary and concluding remarks (Jan Kovac, Alison Halliday)

Watch all the recordings